CIK 1511901
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2019-Q3. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Unclassified | 70.51% | 22 |
| Pharmaceuticals & Biotechnology | 23.11% | 10 |
| Health Care Equipment & Supplies | 6.38% | 3 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | BIODELIVERY SCIENCES INTL IN | Unclassified | 6.75% | |
| 2 | VRAYQ | Viewra, Inc | Unclassified | 5.84% |
| 3 | Amarin Corp PLC | Unclassified | 5.59% | |
| 4 | BIOHAVEN PHARMACTL HLDG CO L | Unclassified | 5.53% | |
| 5 | ALKS | Alkermes plc. | Health Care | 5.24% |
| 6 | QUOTIENT LTD | Unclassified | 4.71% | |
| 7 | EIGER BIOPHARMACEUTICALS INC | Unclassified | 4.58% | |
| 8 | STAA | STAAR SURGICAL CO | Health Care | 4.04% |
| 9 | INTERSECT ENT INC | Unclassified | 3.90% | |
| 10 | PROGENICS PHARMACEUTICALS IN | Unclassified | 3.87% |
13/35 names classified · sector 29.5% of weight · industry 29.5% · mkt cap 29.5%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 29.5% of the book is sector-classified (unclassified names shown, never dropped).
Only 14% of book weight classified — the grid is NOT representative of the whole book.
Classified: 14.5% of book weight (5/18 names) · unclassified 85.5%: , VRAYQ, STAA, IOVA, SLGL, RLMD, XCUR, SSKN, ANAB, ACRS +3 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | BIODELIVERY SCIENCES INTL IN | 4,300,066 | $27M | 6.7% | HOLD |
| 2 | VRAYQViewra, Inc | 5,574,366 | $24M | 5.8% | ADD 86% |
| 3 | Amarin Corp PLC | 1,049,244 | $22M | 5.6% | TRIM −33% |
| 4 | BIOHAVEN PHARMACTL HLDG CO L | 409,338 | $22M | 5.5% | TRIM −23% |
| 5 | ALKSALKERMES PLC | 1,033,500 | $21M | 5.2% | ADD 315% |
| 6 | QUOTIENT LTD | 1,994,183 | $19M | 4.7% | ADD 225% |
| 7 | EIGER BIOPHARMACEUTICALS INC | 1,236,368 | $18M | 4.6% | TRIM −10% |
| 8 | STAASTAAR SURGICAL CO | 462,118 | $16M | 4.0% | NEW |
| 9 | INTERSECT ENT INC | 631,023 | $16M | 3.9% | TRIM −19% |
| 10 | PROGENICS PHARMACEUTICALS IN | 3,060,923 | $16M | 3.9% | ADD 93% |
| 11 | NANOSTRING TECHNOLOGIES INC | 555,600 | $15M | 3.8% | ADD 401% |
| 12 | IOVAIOVANCE BIOTHERAPEUTICS INC | 533,301 | $15M | 3.7% | TRIM −53% |
| 13 | DERMIRA INC | 896,334 | $14M | 3.4% | ADD 55% |
| 14 | SOCIETAL CDMO INC | 721,073 | $13M | 3.3% | TRIM −27% |
| 15 | LNTHLANTHEUS HLDGS INC | 617,953 | $13M | 3.1% | NEW |
| 16 | VAPOTHERM INC | 1,003,099 | $12M | 3.0% | NEW |
| 17 | SIENTRA INC | 1,286,987 | $12M | 2.9% | TRIM −36% |
| 18 | VCELVERICEL CORP | 620,199 | $11M | 2.7% | ADD 162% |
| 19 | LA JOLLA PHARMACEUTICAL CO | 2,688,068 | $11M | 2.6% | ADD 1378% |
| 20 | ALEXION PHARMACEUTICALS INC | 83,100 | $9M | 2.2% | NEW |
| 21 | SLGLSOL GEL TECHNOLOGIES | 521,819 | $9M | 2.2% | TRIM −7% |
| 22 | RLMDRELMADA THERAPEUTICS INC | 220,724 | $9M | 2.1% | NEW |
| 23 | AUPHAURINIA PHARMACEUTICALS INC | 400,000 | $8M | 2.0% | NEW |
| 24 | AVADEL PHARMACEUTICALS PLC | 1,029,012 | $8M | 1.9% | TRIM −67% |
| 25 | XCUREXICURE INC | 2,707,851 | $8M | 1.9% | ADD 17% |
| 26 | ZOGENIX INC. | 134,937 | $7M | 1.7% | TRIM −2% |
| 27 | ICUIICU MED INC | 30,000 | $6M | 1.4% | HOLD |
| 28 | LUMINEX CORP | 207,553 | $5M | 1.2% | NEW |
| 29 | SSKNSTRATA SKIN SCIENCES INC | 1,839,372 | $4M | 1.0% | TRIM −37% |
| 30 | ANABANAPTYSBIO INC | 221,600 | $4M | 0.9% | NEW |
| 31 | ACRSACLARIS THERAPEUTICS INC | 1,888,039 | $4M | 0.9% | ADD 17% |
| 32 | MYLAN NV | 150,000 | $3M | 0.7% | NEW |
| 33 | HRTXHERON THERAPEUTICS INC | 89,730 | $2M | 0.5% | TRIM −9% |
| 34 | SCYXSCYNEXIS INC COM NEW | 2,000,000 | $2M | 0.5% | NEW |
| 35 | PTNPALATIN TECHNOLOGIES INC COM NEW | 1,047,310 | $819,000 | 0.2% | HOLD |
Where this firm's principals came from and which firms its alumni went on to found.
